Kelvin Sham

1 Patent

• US122140512025

  Method of Treating or Ameliorating Metabolic Disorders Using GLP-1 Receptor Agonists Conjugated to Antagonists for Gastric Inhibitory Peptide Receptor (GIPR)

  Amgen Inc.

  0 cites